Drug Facts

Manufacturer
INNOVUS PHARMACEUTICALS, INC. | Aurohealth LLC | APL HEALTHCARE LIMITED
Effective date
2026-10-27
Label type
Human OTC Drug Label
Version
1
Source
daily-update
Hydrated at
2026-10-31 01:02:59

Label at a glance#

ProductGuaifenesin
Active ingredientGUAIFENESIN
Label structure13 sections

Indications and uses

helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Dosage and administration

do not crush, chew, or break extended-release tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: 1 extended-release tablet every 12 hours. Do not exceed 2 extended-release tablets in 24 hours. children under 12 years of age: do not use

Storage and handling

store between 20° to 25°C (68° to 77°F)

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

(in each extended-release tablet)

Guaifenesin USP 1200 mg

Purpose

OTC - PURPOSE SECTION

Expectorant

Uses

INDICATIONS & USAGE SECTION


  • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Warnings

WARNINGS SECTION


Do not use

  • for children under 12 years of age

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION


  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm (mucus)

Stop use and ask a doctor if

OTC - STOP USE SECTION


  • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION


ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION


In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

  • do not crush, chew, or break extended-release tablet
  • take with a full glass of water
  • this product can be administered without regard for the timing of meals
  • adults and children 12 years of age and over: 1 extended-release tablet every 12 hours. Do not exceed 2 extended-release tablets in 24 hours.
  • children under 12 years of age: do not use

Other information

STORAGE AND HANDLING SECTION

  • store between 20° to 25°C (68° to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION


colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, and pregelatinised starch (maize)

Questions?

OTC - QUESTIONS SECTION

1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)

Distributed By: Innovus Pharmaceuticals, Inc.
5740 Kietzke Lane #300, Reno, Nevada 89511
www.crclehealth.com

Made in India

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (14 (2 x 14) Tablets)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

*Compare to the active
ingredient of Maximum
Strength Mucinex®

C•rcle™

NDC 57483-144-28

Maximum Strength
Guaifenesin
Extended-Release Tablets 1200 mg
Guaifenesin 1200 mg - Expectorant
RELIEVES CHEST CONGESTION

12
Hour

  • Relieves chest congestion
  • Thins & loosens mucus

28 EXTENDED-RELEASE TABLETS

Actual Size

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (14 (2 x 14) Tablets)PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (14 (2 x 14) Tablets)


Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
57483-14457483-144-28

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210453-001GUAIFENESINGUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21
A210453-002GUAIFENESINGUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21d4dbc9d85df4…
2026-10-15 13:18:302026-09A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21c2088c7a36db…
2026-10-15 13:18:302026-09A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21c2088c7a36db…
2026-09-14 22:38:342026-08A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-2184e616aacf4f…
2026-09-14 22:38:342026-08A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-2184e616aacf4f…
2026-08-18 06:07:402026-07A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21caaa826d4ba7…
2026-08-18 06:07:402026-07A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-2131067a03dcf5…
2025-08-23 18:47 UTC2025-08A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-216a471c1ec25d…
2025-08-23 18:47 UTC2025-08A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-216a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-2103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-212680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-215bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-215bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21d06236e962d9…
2024-10-29 15:01 UTC2024-10A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-2179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-2179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-211e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-211e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-218072bd15b7f6…
2024-05-31 18:47 UTC2024-05A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-218072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-215c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-215c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-215d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-215d02ea3f76ae…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 13 · 260 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Meijer Adult Mucus Plus chest congestionGUAIFENESINMEIJER DISTRIBUTION, INCf6a23be6-0313-4c23-afb7-576666b80e212026-10-05WarningsName fallback
generic name: GUAIFENESIN
DRx Choice Fruit PunchGUAIFENESINRaritan Pharmaceuticals Inca19d7e1c-c04e-41c6-8af6-ecde962992162026-09-09WarningsName fallback
generic name: GUAIFENESIN
Foster and Thrive Mucus ReliefGUAIFENESINStrategic Sourcing Services LLCf4ab5611-8abb-4c1f-8f85-917e2e1328e32026-09-09WarningsName fallback
generic name: GUAIFENESIN
Mucus ReliefGUAIFENESINStrategic Sourcing Services LLCcd7955b2-8eee-43d3-973f-6de2f39295122026-09-09WarningsName fallback
generic name: GUAIFENESIN
Maximum Strength Mucus ReliefGUAIFENESINStrategic Sourcing Services LLC5a6f88b8-3436-3321-e063-6294a90a3a2e2026-09-09WarningsName fallback
generic name: GUAIFENESIN
good sense mucus erGUAIFENESINL. Perrigo Companydef40c3f-29de-4efc-b1d3-4cb89183aaec2026-09-03WarningsName fallback
generic name: GUAIFENESIN
MAX Tussin Mucus and Chest Congestion Sugar FreeGUAIFENESINAkron Pharma Inc.3b023b91-e703-4599-9864-96d8c328b45c2026-08-31WarningsName fallback
generic name: GUAIFENESIN
MAX Tussin Mucus and Chest CongestionGUAIFENESINAkron Pharma Inc.ac874a31-5556-4669-937f-dcb52aaecd8a2026-08-31WarningsName fallback
generic name: GUAIFENESIN
Curist Mucus Relief Maximum StrengthGUAIFENESINLittle Pharma, Inc.c7d1136c-a712-2ac5-e053-2995a90a4dd42026-08-24WarningsName fallback
generic name: GUAIFENESIN
CVS Adult Mucus chest congestionGUAIFENESINCVS PHARMACYbec04049-03b2-4465-9cf5-0ad2ef8014ef2026-08-19WarningsName fallback
generic name: GUAIFENESIN
CVS Adult Mucus plus Chest CongestionGUAIFENESINCVS PHARMACY3cf425bd-9d90-4c19-a4f7-3cf7bd0b393a2026-08-19WarningsName fallback
generic name: GUAIFENESIN
Mucus ReliefGUAIFENESINP & L Development, LLC3c01a88f-35c8-4e43-9997-ebee7943820f2026-08-10WarningsName fallback
generic name: GUAIFENESIN
GuaifedGUAIFENESINAldama Pharmaceuticals, Inc38f37272-2084-a33b-e063-6294a90ac1502026-08-10WarningsName fallback
generic name: GUAIFENESIN
Mucus Relief Extended Release Maximum StrengthGUAIFENESINCVS Pharmacy34314503-b253-4b44-96ff-a42fe2bb161f2026-07-22WarningsName fallback
generic name: GUAIFENESIN
Mucus Relief ERGUAIFENESINCardinal Health 107, LLCf7abc2ff-21bc-48b5-9989-c5ac84f5c9cd2026-07-21WarningsName fallback
generic name: GUAIFENESIN
mucus reliefGUAIFENESINCVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED51194399-6ded-4142-8880-9e810e6283522026-07-13WarningsName fallback
generic name: GUAIFENESIN
Good Neighbor Adult Tussin Mucus and chest congestionGUAIFENESINAMERISOURCE BERGEN97e9cd18-dd55-4a26-80e3-4c17b9e1a1e82026-07-13WarningsName fallback
generic name: GUAIFENESIN
Guaifenesin 200mgGUAIFENESINHealth Pharma USA LLCd68222f7-b796-7b27-e053-2995a90a2efe2026-07-07WarningsName fallback
generic name: GUAIFENESIN
GuaifenesinGUAIFENESINAurohealth LLC062e3d83-8495-4c8f-b1e6-5eb37fd532242026-07-03WarningsName fallback
brand name: Guaifenesin
generic name: GUAIFENESIN
equate mucus-erGUAIFENESINWALMART INC.a2cc6dec-388a-46bd-9cbc-1ffb6fd1aea32026-07-02WarningsName fallback
generic name: GUAIFENESIN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.